Related references
Note: Only part of the references are listed.IFN/STAT signaling controls tumorigenesis and the drug response in colorectal cancer
Mizuho Sakahara et al.
CANCER SCIENCE (2019)
Differential immune profiles distinguish the mutational subtypes of gastrointestinal stromal tumor
Gerardo A. Vitiello et al.
JOURNAL OF CLINICAL INVESTIGATION (2019)
Oncogenic kinase inhibition limits Batf3-dependent dendritic cell development and antitumor immunity
Benjamin D. Medina et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2019)
Tissue-resident memory T cells at the center of immunity to solid tumors
Derk Amsen et al.
NATURE IMMUNOLOGY (2018)
Macrophages and CD8+ T Cells Mediate the Antitumor Efficacy of Combined CD40 Ligation and Imatinib Therapy in Gastrointestinal Stromal Tumors
Jennifer Q. Zhang et al.
CANCER IMMUNOLOGY RESEARCH (2018)
Mitochondrial Inhibition Augments the Efficacy of Imatinib by Resetting the Metabolic Phenotype of Gastrointestinal Stromal Tumor
Gerardo A. Vitiello et al.
CLINICAL CANCER RESEARCH (2018)
PD-1/PD-L1 Blockade Enhances T-cell Activity and Antitumor Efficacy of Imatinib in Gastrointestinal Stromal Tumors
Adrian M. Seifert et al.
CLINICAL CANCER RESEARCH (2017)
Host STING-dependent MDSC mobilization drives extrinsic radiation resistance
Hua Liang et al.
NATURE COMMUNICATIONS (2017)
The good and the bad faces of STAT1 in solid tumours
Katrin Meissl et al.
CYTOKINE (2017)
Tumor-Residing Batf3 Dendritic Cells Are Required for Effector T Cell Trafficking and Adoptive T Cell Therapy
Stefani Spranger et al.
CANCER CELL (2017)
Inactivation of Interferon Receptor Promotes the Establishment of Immune Privileged Tumor Microenvironment
Kanstantsin V. Katlinski et al.
CANCER CELL (2017)
Tumor Interferon Signaling Regulates a Multigenic Resistance Program to Immune Checkpoint Blockade
Joseph L. Benci et al.
CELL (2016)
Immunological off-target effects of imatinib
Laurence Zitvogel et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2016)
NLRC5/MHC class I transactivator is a target for immune evasion in cancer
Sayuri Yoshihama et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2016)
Suppression of Type I Interferon Signaling Overcomes Oncogene-Induced Senescence and Mediates Melanoma Development and Progression
Yuliya V. Katlinskaya et al.
CELL REPORTS (2016)
Molecular and Genetic Properties of Tumors Associated with Local Immune Cytolytic Activity
Michael S. Rooney et al.
CELL (2015)
Type I IFNs Act upon Hematopoietic Progenitors To Protect and Maintain Hematopoiesis during Pneumocystis Lung Infection in Mice
Justin R. Prigge et al.
JOURNAL OF IMMUNOLOGY (2015)
Direct Activation of STING in the Tumor Microenvironment Leads to Potent and Systemic Tumor Regression and Immunity
Leticia Corrales et al.
CELL REPORTS (2015)
Increased KIT Inhibition Enhances Therapeutic Efficacy in Gastrointestinal Stromal Tumor
Teresa S. Kim et al.
CLINICAL CANCER RESEARCH (2014)
Cancer cell-autonomous contribution of type I interferon signaling to the efficacy of chemotherapy
Antonella Sistigu et al.
NATURE MEDICINE (2014)
Regulation of type I interferon responses
Lionel B. Ivashkiv et al.
NATURE REVIEWS IMMUNOLOGY (2014)
Immune Infiltrates Are Prognostic Factors in Localized Gastrointestinal Stromal Tumors
Sylvie Rusakiewicz et al.
CANCER RESEARCH (2013)
KIT oncogene inhibition drives intratumoral macrophage M2 polarization
Michael J. Cavnar et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2013)
Inferring tumour purity and stromal and immune cell admixture from expression data
Kosuke Yoshihara et al.
NATURE COMMUNICATIONS (2013)
The Management of Gastrointestinal Stromal Tumors: A Model for Targeted and Multidisciplinary Therapy of Malignancy
Heikki Joensuu et al.
ANNUAL REVIEW OF MEDICINE, VOL 63 (2012)
Exploiting antitumor immunity to overcome relapse and improve remission duration
Lei L. Chen et al.
CANCER IMMUNOLOGY IMMUNOTHERAPY (2012)
Imatinib resistance and microcytic erythrocytosis in a KitV558Δ; T669I/+ gatekeeper-mutant mouse model of gastrointestinal stromal tumor
Benedikt Bosbach et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2012)
Direct Effects of Type I Interferons on Cells of the Immune System
Sandra Hervas-Stubbs et al.
CLINICAL CANCER RESEARCH (2011)
Mechanisms of STAT Protein Activation by Oncogenic KIT Mutants in Neoplastic Mast Cells
Amandine Chaix et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2011)
Host type I IFN signals are required for antitumor CD8+ T cell responses through CD8α+ dendritic cells
Mercedes B. Fuertes et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Type I interferon is selectively required by dendritic cells for immune rejection of tumors
Mark S. Diamond et al.
JOURNAL OF EXPERIMENTAL MEDICINE (2011)
Imatinib potentiates antitumor T cell responses in gastrointestinal stromal tumor through the inhibition of Ido
Vinod P. Balachandran et al.
NATURE MEDICINE (2011)
Incidence of Sarcoma Histotypes and Molecular Subtypes in a Prospective Epidemiological Study with Central Pathology Review and Molecular Testing
Francoise Ducimetiere et al.
PLOS ONE (2011)
An interferon-related gene signature for DNA damage resistance is a predictive marker for chemotherapy and radiation for breast cancer
Ralph R. Weichselbaum et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2008)
KIT oncoprotein interactions in gastrointestinal stromal tumors: therapeutic relevance
M-J Zhu et al.
ONCOGENE (2007)
Complex modulation of cell type-specific signaling in response to type I Interferons
Anette H. H. van Boxel-Dezaire et al.
IMMUNITY (2006)
Mechanisms of oncogenic KIT signal transduction in primary gastrointestinal stromal tumors (GISTs)
A Duensing et al.
ONCOGENE (2004)
Gastrointestinal stromal tumors in a mouse model by targeted mutation of the Kit receptor tyrosine kinase
G Sommer et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2003)
STATs: Transcriptional control and biological impact
DE Levy et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2002)
Conventional and molecular cytogenetic characterization of a new human cell line, GIST-T1, established from gastrointestinal stromal tumor
T Taguchi et al.
LABORATORY INVESTIGATION (2002)
Cytokine signaling - STATs in plasma membrane rafts
PB Sehgal et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2002)
A weak signal for strong responses:: Interferon-α/β revisited
T Taniguchi et al.
NATURE REVIEWS MOLECULAR CELL BIOLOGY (2001)
Share Paper
